| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_LPAR1_0005000 | Intron-Exon-Intron | chr9:113734353-113798474 | chr9:110972073-111036194 | 348 nt | 0.4253 |
| hsa_LPAR1_0005100 | Intron-Exon-Intron | chr9:113734353-113799058 | chr9:110972073-111036778 | 148 nt | 0.4932 |
| hsa_LPAR1_0005300 | Intron-Intron | chr9:113734501-113735760 | chr9:110972221-110973480 | 1260 nt | 0.4381 |
| hsa_LPAR1_0005600 | Intron-Exon-Intron | chr9:113735761-113771481 | chr9:110973481-111009201 | 250 nt | 0.2920 |
| hsa_chr9_0074000 | Intergenic-Intergenic | chr9:113737726-113738557 | chr9:110975446-110976277 | 832 nt | 0.3774 |
| hsa_LPAR1_0005700 | Intron-Intron | chr9:113740892-113773970 | chr9:110978612-111011690 | 250 nt | 0.3240 |
| hsa_LPAR1_0005900 | Intron-Intron | chr9:113767745-113798481 | chr9:111005465-111036201 | 155 nt | 0.5548 |
| hsa_LPAR1_0006000 | Intron-Intron | chr9:113768145-113768891 | chr9:111005865-111006611 | 747 nt | 0.3775 |
| hsa_LPAR1_0006300 | Intron-Intron | chr9:113771428-113772620 | chr9:111009148-111010340 | 1193 nt | 0.2674 |
| hsa_LPAR1_0006400 | Intron-Intron | chr9:113771428-113774904 | chr9:111009148-111012624 | 54 nt | 0.2963 |
A study in humans demonstrated that the circLPAR1 is expressed at low levels in muscle-invasive bladder cancer (MIBC) tissues, where its low expression predicts worse disease-specific survival and is associated with invasion and metastasis [Di Agostino et al. DOI:10.3389/fcell.2020.00389].